A purine analog synergizes with chloroquine (CQ) by targeting Plasmodium falciparum Hsp90 (PfHsp90).
Drug resistance, absence of an effective vaccine, and inadequate public health measures are major impediments to controlling Plasmodium falciparum malaria worldwide. The development of antimalarials to which resistance is less likely is paramount. To this end, we have exploited the chaperone functio...
Main Authors: | Dea Shahinas, Asongna Folefoc, Tony Taldone, Gabriela Chiosis, Ian Crandall, Dylan R Pillai |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3787104?pdf=render |
Similar Items
-
Targeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial Resistance
by: Dea Shahinas, et al.
Published: (2013-02-01) -
The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1
by: Li Zihai, et al.
Published: (2010-10-01) -
Overexpression, Purification and Characterisation of the Plasmodium falciparum Hsp70-z (PfHsp70-z) Protein.
by: Tawanda Zininga, et al.
Published: (2015-01-01) -
The Malarial Exported PFA0660w Is an Hsp40 Co-Chaperone of PfHsp70-x.
by: Michael O Daniyan, et al.
Published: (2016-01-01) -
Plasmodium falciparum Hep1 Is Required to Prevent the Self Aggregation of PfHsp70-3.
by: David O Nyakundi, et al.
Published: (2016-01-01)